Status:
COMPLETED
Leveraging Social Networks to Increase COVID-19 Testing Uptake
Lead Sponsor:
New York State Psychiatric Institute
Collaborating Sponsors:
Alliance for Postive Change
Argus Community Inc.
Conditions:
Covid-19
Substance Use
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
This two-year project will adapt and conduct a trial examining the ability of two recruitment strategies, chain-referral and credible messenger, to reach those who use opioids and other substances in ...
Detailed Description
Aims. Building on the expertise and community out-reach infrastructure of two community-based organizations (CBOs), Argus Community Inc. and Alliance for Positive Change, and following a CBPR approach...
Eligibility Criteria
Inclusion
- Endorse opioid use in the past 6 months
- Speak English or Spanish
- Age 18+
Exclusion
- Deny history of opioid use (but will be offered COVID-19 testing)
Key Trial Info
Start Date :
April 20 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2023
Estimated Enrollment :
498 Patients enrolled
Trial Details
Trial ID
NCT04873401
Start Date
April 20 2021
End Date
January 1 2023
Last Update
February 19 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
New York State Psychiatric Institute
New York, New York, United States, 10032